Regeneron Pharmaceuticals | Netto Inntekt



Net Income Endring Dato
AbbVie USD 1.29B 1.31B 2025-03
Agios Pharmaceuticals USD -96523000 1.04B 2024-12
Alnylam Pharmaceuticals USD -83763000 27.81M 2024-12
Amgen USD 627M 2.2B 2024-12
Astellas Pharma JPY 74.9B 172.56B 2025-03
AstraZeneca USD 2.92B 1.42B 2025-03
Biogen USD 266.7M 121.8M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Incyte USD 158.2M 43.01M 2025-03
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
J&J USD 11B 7.57B 2025-03
Kyowa Hakko Kirin JPY 6.17B 11.96B 2025-03
Merck USD 5.08B 1.34B 2025-03
Moderna USD -971000000 149M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 499M 2.32B 2024-12
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
Teva Pharmaceutical Industries USD -217000000 220M 2024-12
Ultragenyx Pharmaceutical USD -133385000 131K 2024-12
United Therapeutics USD 322.2M 20.9M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Regeneron Pharmaceuticals Netto Inntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.